Short- and long-term adverse events in patients on temporary circulatory support before durable ventricular assist device: An IMACS registry analysis
Patients with cardiogenic shock (CS) needing temporary circulatory support (TCS) have poor survival rates after implantation of durable ventricular assist device (dVAD). We aimed to characterize post-dVAD adverse event burden and survival rates in patients requiring pre-operative TCS.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Van-Khue Ton, Rongbing Xie, Jaime A. Hernandez-Montfort, Bart Meyns, Takeshi Nakatani, Masanobu Yanase, Steve Shaw, Stephen Pettit, Ivan Netuka, James Kirklin, Daniel J. Goldstein, Jennifer Cowger Tags: Original Clinical Science Source Type: research
More News: Cardiogenic Shock | Cardiology | Heart | Heart Transplant | Lung Transplant | Science | Transplant Surgery | Transplants